At the beginning of August, a first batch of a diagnostic medicine made in Russia, which helps to detect tuberculosis in the early stages had been delivered to Republic of Cuba. The first delivery of Tuberculin produced by FSUE St. Petersburg Research Institute of Vaccines and Serums and the Bacterial Preparation Factory (SPbSRIVS) was successfully

Director of SPbSRIVS Mr. Victor Trukhin y CEO of Mechnikov S.A. Mr. Stanislv Uiba took part in celebrations dedicated to the day of Nicaraguan Revolution. As part of the celebrations were held working meetings with the Nicaraguan colleagues of MECHNIKOV project. To remind, the Revolution Day is celebrated in Nicaragua at the national level on

The first shipment to Latin America of the Russian vaccine against yellow fever was the result of joint efforts by the St. Petersburg Research Institute of Vaccines and Serums (SPbSRIVS) of the Russian Federal Biomedical Agency and the Chumakov Federal Research Center for Research and Development of Immunobiological Preparations at the Russian Academy of Sciences.

Another meeting of the technical committee dedicated to the cooperation between Russia and Nicaragua as part of the vaccine technology transfer project was held. The meeting was attended by Mr. Victor Trukhin, Director of SPbSRIVS, and Mr. Stanislav Uiba, CEO at Mechnikov S.A.

As part of the official visit to Venezuela of the Russian Deputy Prime Minister for Defense Industry Mr. Dmitry Rogozin, the Director of SPbSRIVS of the Russian Federal Biomedical Agency Mr. Victor Trukhin and the Minister of Health of Venezuela Ms. Luisana Melo signed a memo of understanding providing for an assessment of the cooperation

On October 22, 2016 Managua, the capital of Nicaragua, hosted an official event celebrating the construction completion of Latin America’s first immunobiological vaccine factory – Mechnikov. The ceremony was attended by the Minister of Health of Russia Ms. V.I. Skvortsova, Head of FMBA of Russia Mr. V.V. Uiba, PAHO/WHO Director Ms. Carissa F. Etienne, Director

September 30, 2016, a meeting of the co-chairs of the Intergovernmental Russian-Nicaraguan Commission on Trade, Economic, Scientific, and Technology Cooperation was held in Moscow. Deputy Director of SPbSRIVS, Mr. Andrey Vasiliev, presented a new project envisaging a new pharmaceutical facility in Managua, Nicaragua, to synthesize influenza vaccines using an imported Russian active component, under development